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TheBackground: Adhesion molecules are involved in inflammatory processes that alter
endothelial function and lead to impairment of coronary vasomotor function. We
studied a possible relationship between systemic expression, cardiac-specific ex-
pression, or both of P-selectin and intercellular adhesion molecule 1 and coronary
vasomotor function both 1 and 12 months after heart transplantation in human
subjects.
Methods: The expression of endomyocardial and soluble forms of P-selectin and
intercellular adhesion molecule 1, as well as levels of tumor necrosis factor , were
determined in aortic and coronary sinus blood samples 1, 6, and 12 months after
heart transplantation in 42 transplant recipients and 20 age-matched, nontrans-
planted control subjects. In addition, both endothelium-dependent (acetylcholine)
and endothelium-independent (adenosine) coronary vasomotor function were as-
sessed by using a Doppler flow wire and quantitative coronary angiography 1 and
12 months after heart transplantation.
Results: Adhesion molecules were highly expressed 1 month after heart transplan-
tation and remained at high levels 12 months after heart transplantation when
compared with levels in nontransplanted control subjects. No cardiac-specific ex-
pression or release of P-selectin or intercellular adhesion molecule 1 was observed.
There was a significant inverse correlation between coronary vasomotor function
and soluble adhesion molecule expression both 1 and 12 months after heart trans-
plantation.
Conclusion: Persistently high levels of circulating adhesion molecules are of sys-
temic, but not cardiac-specific, origin and reflect a chronic inflammatory state
throughout the first year after heart transplantation. This is associated with impair-
ment of coronary vasomotor function, an early and potentially reversible step in the
process of atherothrombosis and transplant coronary artery disease.
Soluble adhesion molecules have been shown to be markers and mediators ofendothelial dysfunction in various disease states, including arteriosclerosis,myocardial infarction, and heart failure.1 It has been shown that early ex-
pression of both P-selectin and intercellular adhesion molecule 1 (ICAM-1) is
predictive of future cardiovascular events in apparently healthy men and in patients
with documented coronary artery disease.2,3
Cardiac transplantation has been the established treatment of choice for end-stage
heart failure of various causes. However, the limiting factor for long-term survival
Journal of Thoracic and Cardiovascular Surgery ● Volume 130, Number 4 1175.e1
Cardiothoracic Transplantation Wildhirt et alis the progressive development of transplant coronary artery
disease. The disease process leads to vanishing of small
intramyocardial resistance vessels but also involves epicar-
dial conduit vessels. Its nature is multifactorial, consisting
of immunologic and classic cardiovascular risk factors.4
One early predictor of transplant coronary artery disease is
the development of endothelial dysfunction in response to
endothelium-dependent and endothelium-independent vaso-
dilators.5,6
Increased circulating adhesion molecule levels serve as
markers and mediators for future cardiovascular events. In
addition, it has been shown that during chronic rejection,
P-selectin expression correlated with the intensity of arterial
intimal thickening.7 However, it remains unclear whether
soluble adhesion molecules are of systemic or cardiac-
specific origin. Moreover, a direct association between cir-
culating adhesion molecules and coronary vasomotor dys-
function has not been shown. This prompted us to investi-
gate the potential role of systemic expression, cardiac-
specific expression, or both of soluble P-selectin and
ICAM-1 in the development of coronary endothelial dys-
function in human heart transplant recipients.
Material and Methods
A total of 62 patients, including 42 heart transplant recipients and
20 age-matched control subjects, undergoing coronary artery by-
pass grafting were included in this prospective and longitudinally
designed study. The demographics are given in Table 1.
In transplant recipients triple-drug immunosuppression based
on tacrolimus or cyclosporine (INN: ciclosporin) in combination
with myocophenolate was initiated immediately after organ im-
plantation and was maintained throughout the study. Other medi-
cations, including angiotensin-converting enzyme inhibitors, cal-
cium antagonists, statins, and diuretics, were discontinued 24 to 48
hours before each examination. All patients agreed to participate in
the study and provided written informed consent. The study pro-
tocol was approved by the Ethics Committee at the University of
Munich, Germany. No study-related complications and no deaths
occurred during the 1-year follow-up.
Blood samples from 20 age-matched, nontransplanted control
subjects undergoing coronary bypass surgery with the use of
cardiopulmonary bypass were collected at similar time points to
Abbreviations and Acronyms
Ach  acetylcholine
CFVR  coronary flow velocity reserve
HTx  heart transplantation
ICAM-1 intracellular adhesion molecule 1
IVUS  intravascular ultrasound
Co  control
LAD  left anterior descending coronary artery
TNF-  tumor necrosis factor account for differences in adhesion molecule and cytokine expres-
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cardiac surgical procedure with cardiopulmonary bypass per se
and the effects of the alloimmune response under immunosuppre-
sive therapy (demographics are shown in Table 1).
Study Protocol
Left heart catheterization was performed at 1 and 12 months after
heart transplantation (HTx) and consisted of a measurement of
hemodynamics and routine coronary angiography to exclude do-
nor-transmitted coronary artery disease. In addition, endothelium-
dependent and endothelium-independent epicardial (quantitative
coronary angiography) and microvascular (Doppler flow wire)
coronary vasomotor function were assessed.
Blood samples were drawn from the peripheral vein, coronary
sinus, and aorta. Endomyocardial biopsy specimens were obtained
from the interventricular septum for determination of ICAM and
P-selectin protein expression at months 1, 6, and 12 after trans-
plantation. To account for differences in sample quality, we always
used tissues from 2 biopsy samples for immunohistochemistry.
Functional Assessment of Coronary Vasomotor
Function
Measurement of coronary vasomotor response (assessed by means
of quantitative coronary angiography and intracoronary Doppler
flow measurement) and intimal thickening has been described
previously.8
In brief, after administration of 5000 units of heparin, a Dopp-
ler flow wire (0.018 in [0.04 cm]; Flowire, Cardiometrics Inc) was
placed in the proximal left anterior descending coronary artery
(LAD) to assess coronary blood flow velocities continuously. After
baseline flow velocity readings were obtained, adenosine (80.0 and
160.0 g/min for 5 minutes each; Adrekar, Sanofi-Winthrop) was
infused to assess maximal endothelium-independent coronary
flow. Thereafter, epicardial and microvascular endothelial coro-
nary vasomotor function was determined with intracoronary ad-
ministration of acetylcholine (Ach; 1.0 and 30.0 g/min for 5
minutes each; estimated final concentration in the coronary bed,
107 to 3  108 mol/L; Acetylcholine Dispersa, Germering).
At the end of each infusion, coronary arteriography was per-
formed and analyzed off-line by using quantitative coronary
angiography.
Coronary Flow Reserve
Coronary flow velocity reserve (CFVR), a marker of microvascu-
lar integrity, was expressed as the ratio of peak to baseline blood
flow velocity. Heart rate, mean arterial pressure, coronary flow
velocity, and electrocardiography were monitored continuously
throughout the procedure. It was ensured that measurements of the
flow velocity reserve of the microvascular bed were not altered by
epicardial vasoconstriction. No epicardial vasoconstriction of
greater than 50% during Ach infusion was observed.
An increase in flow velocity of a factor of less than 2.0 was
considered pathologic, as described previously.9
Quantitative Coronary Angiography
Epicardial vasomotor response was assessed with a computerized
automatic-analysis system (Hicor, Siemens). Nonstenotic proximal
and distal coronary arterial segments identified between easily
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Responses to the different pharmacologic stimuli were expressed
as percentage changes versus baseline value and calculated as the
average between the 2 segments analyzed. Intraobserver and in-
terobserver variability showed high reproducibility (r  0.89, P 
.0001). Epicardial endothelial dysfunction has been described as a
greater than 10% diameter reduction in response to Ach compared
with baseline values.8
Intravascular Ultrasonography
After Doppler flow measurement, intravascular ultrasonography
(IVUS) was performed to detect atherosclerotic changes not visi-
ble with angiography. The imaging system consisted of a 30-MHz
ultrasound transducer enclosed within an acoustic housing on the
tip of a 2.9F flexible, rapid exchange catheter (CVIS Inc). The
catheter was advanced to the distal LAD or left circumflex artery,
carefully observing a lumen-IVUS catheter diameter ratio of
greater than 1.5. During the standard pullback maneuvers, images
were documented on the SVHS Videosystem for further analysis.
The 3 sites with the most prominent intimal proliferation were
analyzed, and the averaged maximal intimal thickness (the greatest
distance from the intimal leading edge to the media-adventitia
TABLE 1. Demographics of heart transplant recipients and
HT
Study examination (days after the operation)
Age (y) 52
Weight (kg) 72
Height (cm) 1
Sex (M:F), n (%) male
Number of CAD risk factors per patient
Native CAD risk factors
Diabetes, n (%)
Hypertension, n (%)
Hyperlipidemia, n (%)
Tobacco, n (%)
Hyperuremia, n (%)
Alcohol, n (%)
Creatinine (mg/dL) 1
Cholesterol (mg/dL) 1
LDL (mg/dL) 1
HDL (mg/dL)
Lp(a) (mg/dL)
C-reactive protein (mg/dL) 1
Ejection fraction (%)
MAP
LVEDP
ACE inhibitor (%)
Statins (%)
Diuretics (%)
Calcium antagonists (%)
-Blockers (%)
Relevant demographics of recipients and nontransplanted control subjects
surgery. CAD, Coronary artery disease; LDL, low-density lipoprotein; HDL, hi
left ventricular end-diastolic pressure; ACE, angiotensin-converting enzymborder) was calculated.
The Journal of Thoracic anAll segments studied were classified according to both severity
of intimal thickening and the degree of circumferential involve-
ment to categorize the degree of coronary disease. The following
definitions were applied: class 0, no intimal thickening; class 1,
mild intimal thickening (intimal layer 300 m thick involving
180° of vessel circumference); class 2, moderate intimal thick-
ening (intimal layer 300-500 m thick but involving 180° of
vessel circumference or 500 m thick at any point of the vessel
cross-section); class 3, severe intimal thickening (intimal layer
500 m thick but involving 180° of vessel circumference or
1 mm thick at any point of the vessel cross-section).
The analysis was performed by observers without knowledge
of the results of endothelial function or cytokine or adhesion
molecule levels.
Measurement of Tumor Necrosis Factor  and Soluble
Adhesion Molecules
Plasma levels were measured by using a commercially available
enzyme-linked immunoabsorbant assay (TNF-; Medgenix
GmbH; P-Selectin and ICAM-1, R&D System Europe). Blood
samples were immediately placed on ice and centrifuged. Plasma
was separated, frozen in liquid nitrogen, and stored at80°C until
trol subjects
pients
42)
Control subjects
(n  20) P value
8 31 12 .74
11.2 53.6 9.5 .87
12 76.5 8 .30
8 175 10 .38
2) 17 (93) .12
1 1.36 .67
4) 8 (12) .67
9) 10 (19) .58
0) 7 (51) .66
8) 11 (55) .06
2) 2 (10) .53
) 2 (10) .57
0.4 1.4 0.4 .77
18 201 21 .66
13 112 11 .44
8 44 9 .71
10 31 12 .29
0.5 2.1 0.6 .37
9 57 8 .62
12 75 11 .53
7 13 8 .71
1 45 .43
2 58 .61
5 61 .58
8 42 .31
5 45 .35
time of follow-up after transplantation or coronary artery bypass grafting
nsity lipoprotein; Lp(a), lipoprotein A;MAP, mean arterial pressure; LVEDP,con
x reci
(n 
37
.4
.5
74
38 (8
1.3
6 (1
8 (1
21 (5
16 (3
5 (1
3 (7
.3
91
17
47
24
.6
64
77
14
3
6
5
4
3
at the
gh-defurther processing. Standards were prepared, and the appropriate
d Cardiovascular Surgery ● Volume 130, Number 4 1175.e3
Cardiothoracic Transplantation Wildhirt et alvolume of sample or standard was added to a 96-well polystyrene
microtiter plate precoated with the monoclonal antibody against
tumor necrosis factor  (TNF-). All samples were run in dupli-
cate. Each well was then aspirated, and the plates were washed
with the specific surfactant provided by the manufacturer. An
enzyme-linked polyclonal antibody against the cytokine was
added. Substrate solution was added to each well, and the optical
density was read at the appropriate wavelength for each assay.
Immunohistochemical Detection of Cardiac Adhesion
Molecule Expression
Interventricular biopsy specimens were cut into sections (3 m
in thickness). At least 10 sections from each biopsy specimen
were analyzed. Adjacent cryosections were used for detection
of P-selectin and ICAM-1. In brief, sections were fixed with
chloroform (30 minutes) and blocked with 1.5% H2O2 (10
minutes). After washing (2  5 minutes), nonspecific binding
was blocked with protein serum free block (Dako). For detec-
tion of P-selectin (dilution 1:300; Dako) and ICAM-1 (dilution
1:600; Dako), monoclonal antibodies were incubated for 30
minutes. After washing (3  5 minutes), a secondary antibody
(EnVision; Dako) was applied for 30 minutes and visualized
with a peroxidase substrate AEC kit (Vector Labs). After rins-
ing, sections were counterstained with Mayer’s hemalum solu-
tion and mounted. All steps were performed at room tempera-
ture. Negative controls were obtained by omitting the primary
antibody. Quantification of specific immunoreactivity was not
performed because only small biopsy samples were taken from
the interventricular septum. We believe that this would lead to
overinterpretaion of the data obtained.
Statistical Analysis
Data are presented as mean values standard deviation. Nonpara-
metric data were analyzed by using the Mann-Whitney U test, and
correlations were determined with the Spearman rank test. Multi-
ple comparisons were performed by means of analysis of variance,
followed by Bonferroni post-hoc analysis. The Student t test for
paired and unpaired comparisons was used as appropriate. Dichot-
omous variables were analyzed with the 2 test. The correlation
coefficient was determined by means of simple regression analysis.
Results
Patient Characteristics
None of the patients included in the investigation had clin-
ical signs of infection or acute rejection episodes of Inter-
national Society for Heart and Lung Transplantation grade
1b or greater during the time of sample collection and
functional assessment of the coronary vasculature. More-
over, no significant differences with regard to the number of
acute cellular rejection episodes were found.
The patients did not differ with regard to the number of
classic atherosclerotic risk factors, such as hypertension,
hyperlipdemia, diabetes, or history of smoking (Table 1).
In addition, no significant differences with regard to
cardiac hemodynamics were observed at either follow-up
appointment. Data are depicted in Table 1.
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Angiographic Findings
At 1 month after HTx, no differences concerning the extent
of coronary intimal thickening were observed between pa-
tients with impaired and normal endothelium-dependent
CFVR (Table E1). In addition, no evidence for coronary
lesion formation was observed by means coronary angiog-
raphy at 1 and 12 months after transplantation.
Systemic and Cardiac-specific Adhesion Molecule
Expression
Adhesion molecules were highly expressed 1 month after
HTx and remained at high levels when compared with those
seen in age-matched healthy control subjects (Figure 1, A
and B; P-selectin—Co: 34.3  5.8; HTx: 1 month, 78.8 
9.3; 6 months, 65.1  6.8; 12 months, 47.3  2.9 [P  .05,
all HTx vs Co]; ICAM-1—Co: 140.2  12.8; HTx: 1
month, 286.7  28.3; 6 months, 195.8  11.3; 12 months,
192.4  10.2 [P  .05]). No significant transcardiac pro-
duction or release of adhesion molecules was detected (Fig-
ure 1, C and D). TNF- levels remained high throughout the
first year (Figure E1, A; Co: 1 month, 10.6  3.8; 6 months,
5.8 3.8; HTx: 1 month, 19.5 2.3; 6 months, 21.5 4.8;
12 months, 24.3  4.1 [P  .05, all HTx vs Co]). A
significant transcardiac release was noted and expressed as
the difference between aortic and coronary sinus levels 1
year after HTx (Figure E1, B). There was no significant
correlation between plasma levels of immunosuppressive
drugs and adhesion molecule or cytokine expression.
Immunohistochemical analysis of endomyocardial bi-
opsy specimens at 1 and 12 months after HTx did not reveal
differences between patients with or without impairment of
microvascular CVFR (Figure 2). Two biopsy samples from
each time point were used; however, semiquantification of
endomyocardial P-selectin and ICAM-1 immunoreactivity
was not performed in this setting.
Moreover, there was a close and significant correlation
between the proinflammatory cytokine TNF- and adhesion
molecules (Figure E2).
Coronary Vasomotor Function
Cardiac hemodynamics, including heart rate and mean
blood pressure, were not altered by the administration of
each drug.
Epicardial coronary diameter change after administration
of Ach resulted in luminal constriction of 5%  2% in
proximal and 11%  5% in distal segments at 1 month
and 7%  3% in proximal and 12%  4% in distal
segments at 12 months after HTx. No differences were
found between patients with or without microvascular va-
somotor dysfunction. Endothelium-independent epicardial
vasomotor response (adenosine) was 7%  3% in proximal
segments and 17%  6% in distal segments at 1 month,
ctober 2005
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 8% in distal segments seen 12 months after HTx.
Epicardial vasomotor responsiveness to both Ach and
adenosine were not associated with each other.
CFVR response to intracoronary Ach 1 month after
HTx was impaired (2.0) in 11 (26.1%) of 42 patients.
At 1 year after transplantation, 13 (31%) patients pre-
sented with an impaired CFVR. There was an inverse
correlation between CFVR in response to Ach and P-
selectin both at 1 and 12 months after HTx (Figure 3, A
and B). In addition, CFVR after intracoronary Ach was
significantly associated with higher levels of ICAM-1 at
12 months after HTx (Figure 3, C ). Finally, there was an
inverse correlation between impaired CFVR after Ach
infusion and coronary sinus TNF- levels (R  0.31, P
Figure 1. Adhesion molecules were highly expressed
when compared with levels in age-matched healthy
production of release, expressed as the differences
molecules, was detected (C and D). HTx, Heart transp .02) at 1 month after transplantation.
The Journal of Thoracic anDiscussion
The major findings of the present study are as follows. First,
cardiac transplant recipients express persistently high levels
of the circulating adhesion molecules P-selectin and
ICAM-1 in the absence of acute rejection episodes or in-
fection. Second, the levels of adhesion molecules appear of
systemic origin because no cardiac-specific production or
release was observed. Third, circulating adhesion molecule
expression correlates with the severity of endothelium-
dependent coronary vasomotor dysfunction early and 1 year
after HTx.
Origin and Specificity of Soluble Cell Adhesion
Molecules in Transplant Recipients
In the present study no cardiac-specific production or re-
nth after transplantation and remained at high levels
trol subjects (A and B). No significant transcardiac
een aortic and coronary sinus levels of adhesion
tion; ICAM-1, intercellular adhesion molecule 1.1 mo
con
betw
lantalease of adhesion molecules was detected, and one could
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after HTx. It also raises the issue of whether increased
P-selectin levels, ICAM-1 levels, or both reflect endothelial
cell dysfunction, platelet activation, or both.
Potential sources for circulating P-selectin are the
Weibel-Palade of endothelial cells and the -
Figure 2. Representative immunohistochemical analysis of endo-
myocardial biopsy specimens at 1 month after heart transplanta-
tion did not reveal differences in P-selectin and intercellular
adhesion molecule 1 (ICAM-1) protein expression between pa-
tients with or without impairment of endothelium-dependent cor-
onary flow velocity reserve (CVFR). Two biopsy samples from
each time point were used. However, quantification of endomyo-
cardial P-selectin and ICAM-1 immunoreactivity was not per-
formed in this setting.
Figure 3. There was an inverse correlation between en
in response to acetylcholine (Ach) and P-selectin both
B). In addition, CFVR after intracoronary Ach was si
adhesion molecule 1 (ICAM-1) at 12 months after heart tran
1175.e6 The Journal of Thoracic and Cardiovascular Surgery ● Ogranules of platelets.10,11 In the present study impairment of
coronary vasomotor function was associated with increased
P-selectin levels, pointing to the endothelial cell as an
important source. However, there is evidence that platelets
might be one predominant cell fragment to release P-selec-
tin under conditions of inflammation. Activated platelets
express P-selectin on their surface, which binds to P-selectin
glycoprotein ligand-1 on leukocytes and monocytes to form
platelet-leukocyte aggregates.12 Indeed, activated platelets
per se might not transmigrate through the endothelial layer,
and platelet-leukocyte aggregate formation is one critical
step in the initiation of atherothrombosis. However, acti-
vated platelets exacerbate atherosclerosis development,
whereas blockade or elimination of P-selectin function re-
duced the atherogenesis in mice.13
ICAM-1 belongs to the immunoglobulin superfamily
and is widely expressed at a basal level. It might be
activated by inflammatory cytokines, including TNF-,
in leukocytes and endothelial cells. In the present study
TNF- levels remained increased throughout the first
year when compared with those in control subjects, and a
significant transcardiac release was observed at 12
months, even under immunosuppression sufficient to pre-
vent acute rejection. It correlated with both ICAM-1 and
P-selectin levels, suggesting that this inflammatory pro-
cess is an immunologic phenomenon leading to endothe-
lial vasomotor dysfunction.
In this regard the increased levels of soluble ICAM-1
associated with endothelial vasomotor dysfunction might
point to the vessel wall as an important source during
inflammation. However, in endomyocardial biopsy speci-
mens from the allografts, no obvious differences in protein
lium-dependent coronary flow velocity reserve (CFVR)
and 12 months after heart transplantation (HTx; A and
cantly associated with higher levels of intercellulardothe
at 1
gnifisplantation (C).
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out impaired coronary vasomotor function. Furthermore, the
cellular source of both soluble forms in cardiac allograft
recipients or in patients with acute coronary syndromes is
not entirely clear. One favorable hypothesis is the increased
proteolytic cleavage or shedding from the cell surface, thus
reflecting the increased expression of membrane-bound ad-
hesion molecules.14 Other potential mechanisms include
increased gene transcription, translational changes, or re-
lease of spliced forms.15
Chronic Systemic Inflammation and Coronary
Vasomotor Dysfunction
Under homeostatic conditions, the endothelium maintains
normal vascular tone and blood fluidity, and there is little
to no expression of proinflammatory factors. However,
various known and, to date, unknown factors, including
cardiovascular disease risk factors, initiate a chronic in-
flammatory process that is accompanied by a loss of
vasodilator and antithrombotic factors and increase va-
soconstrictor and prothrombotic products.16
In the present study an enhanced expression of circulat-
ing adhesion molecules associated with coronary vasomotor
dysfunction was observed in the absence of acute inflam-
matory processes such as infection and under immunosup-
pressive therapy sufficient to prevent acute rejection epi-
sodes. This suggests a chronic subtle inflammatory process
triggered either by the recipient’s alloimmune response, the
graft itself by controlling the trafficking of effector T cells,
or by other factors, such as immunosuppressive drugs and
the number of established risk factors of atherogenesis.17-19
Despite the potential for therapeutic interventions, an
important aspect of vasomotor dysfunction and circulation
blood markers of endothelial function is their prognostic
value.20 In this regard, Halcox and colleagues21 identified
the pathologic coronary vasomotor response to Ach as an
independent predictor of cardiovascular events, including
CVD-induced death, myocardial infarction, and stroke. In
addition, Hollenberg and associates5 demonstrated that
heart transplant recipients with the predefined study end
points of transplant vasculopathy and cardiac death showed
more rapid decreases in endothelial function in serial
studies.
Moreover, Ridker and coworkers22 reported that in-
creased baseline levels of soluble adhesion molecules in
apparently healthy women were associated with increasing
risks for future myocardial infarction, stroke, coronary re-
vascularization, and cardiovascular death. In addition, en-
hanced soluble ICAM levels were associated with poor
prognosis in patients with known CAD and was an inde-
pendent predictor for future cardiovascular events.2,23 Fi-
nally, in a study by Pethig and colleagues,18 it was shown
that patients with an active progressing form of transplant
coronary artery disease had higher levels of highly sensitive
The Journal of Thoracic anC-reactive protein, suggesting a systemic inflammatory
state that at least reflects an ongoing atherosclerotic process.
Adhesion Molecules: Therapeutic Targets in
Transplant Coronary Atherothrombosis?
The present data, together with data from previous reports,
support the hypothesis that the early initiation of chronic
inflammatory processes, including leukocyte rolling, tether-
ing, attachment, and transmigration, are critical events in
early atherothrombosis, as reflected by an impaired endo-
thelial vasomotor function.15,19,22,24,25 This suggests that
soluble adhesion molecules not only might be markers but
also targets for therapeutic strategies. However, it remains
uncertain whether long-term blockade of selectins or immu-
noglobulins, such as ICAM-1, would be a practical therapy
under conditions of chronic inflammation. Indeed, selectins
are required for effective neutrophil recruitment, and pa-
tients who lack selectins or their ligands have recurrent
bacterial infections. On the other hand, partial inhibition
might allow host defense to function sufficiently. In this
regard it has been shown that a greater than 90% inhibition
of selectins is necessary to effectively inhibit neutrophil
recruitment.26 Another important aspect of selectin recruit-
ment might be the relative organ specificity. With regard to
the ischemia-reperfusion and inflammatory-type lesion, P-
selectin is important for the heart and kidneys but not the
lungs and liver. This highlights our incomplete understand-
ing of the platelet-leukocyte adhesion cascade.27
Summary
The present study demonstrates an ongoing chronic subtle
inflammatory process in heart transplant recipients early and
1 year after transplantation. It is reflected by persistently
increased systemic P-selectin and ICAM-1 levels associated
with coronary endothelial vasomotor dysfunction in the
absence of acute rejection episodes or infection. It appears
that the heart allograft per se is not the main source for
adhesion molecule release.
Further studies are required as to why transplant recipi-
ents, even when receiving immunosuppressive therapy suf-
ficient to prevent acute rejection episodes, express systemic
and persistently high levels of circulating adhesion mole-
cules associated with impaired endothelium-dependent cor-
onary vasomotor function.
We thank Dr Michael Weis and Dr Sinan Pehlivanly for ex-
cellent technical assistance (catheter studies) and all the members
of the Heart Transplant Team of the University of Munich for their
support.
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Wildhirt et al Cardiothoracic TransplantationFigure E1. Tumor necrosis factor  (TNF-) levels remained high throughout the first year (A). A significant
transcardiac release, expressed as the difference between aortic and coronary sinus levels, was noted 1 year after
heart transplantation (HTx; B).
TABLE E1. Coronary intimal thickening as detected by means of IVUS at 1 month after heart transplantation
Impaired CFVR (n  11) Normal CFVR (n  31) P value
Normal morphology, n (%) 6 (54.5) 15 (48.4) NS
Mean maximum intimal
thickening, n (%)
Predominant localization Predominant localization
Proximal Distal Diffuse Proximal Distal Diffuse
Mild intimal thickening 3 (27.3) 0 0 11 (35.4) 0 0 NS
Moderate intimal thickening 0 0 1 (9.1) 1 (3.2) 0 2 (6.5) NS
Severe intimal thickening 0 0 1 (9.1) 0 0 2 (6.5) NS
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Cardiothoracic Transplantation Wildhirt et alFigure E2. A close and significant correlation between the proinflammatory cytokine tumor necrosis factor 
(TNF-) and P-selectin at 1 year after heart transplantation (HTx) is shown (A). In addition, there was a significant
inverse correlation between TNF- and intercellular adhesion molecule 1 (ICAM-1) both at 1 month and 1 year after
heart transplantation (B and C).1175.e10 The Journal of Thoracic and Cardiovascular Surgery ● October 2005
